ABL Bio Inc. (298380.KQ) KOE

88,800.00

+3000(+3.50%)

Updated at October 20 09:14AM

Currency In KRW

Valuation

Market Cap1.44T
Enterprise Value1.42T
P/E Ratio-69.47
PEG Ratio-0.98
Price/Sales Ratio43.64
Price/Book Ratio22.64
Enterprise/Revenue42.7
Enterprise/EBITDA-231.28

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.63
Operating Margin-0.23

Management Effectiveness

Return On Assets-0.25
Return On Equity-0.36

Income Statement

Revenue33.4B
Revenue/Share1,957.05
Gross Profit33.4B
EBITDA-53.15B
Net Income-55.53B
Diluted EPS-1,157.23

Balance Sheet

Total Cash137.86B
Total Cash/Share2,842
Total Debt43.38B
Total Debt/Equity0.24
Current Ratio2.35
Book Value Per Share3,789.73

Price History

52-Week Change107.75
52-Week High112,300
52-Week Low25,950
Moving Average 50 Days91,420
Moving Average 200 Days62,558.25

Statistics

Average Volume1.03M
Shares Outstanding48.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A